Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Change in Receivables (2022 - 2025)

PAVmed (PAVM) has 4 years of Change in Receivables data on record, last reported at -$7000.0 in Q2 2025.

  • For Q2 2025, Change in Receivables fell 104.61% year-over-year to -$7000.0; the TTM value through Sep 2025 reached -$13000.0, changed N/A, while the annual FY2024 figure was -$43000.0, 197.73% down from the prior year.
  • Change in Receivables reached -$7000.0 in Q2 2025 per PAVM's latest filing, up from -$8000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $152000.0 in Q2 2024 and bottomed at -$111000.0 in Q1 2022.
  • Average Change in Receivables over 4 years is $461.54, with a median of $2000.0 recorded in 2024.
  • Peak YoY movement for Change in Receivables: skyrocketed 985.71% in 2024, then crashed 233.33% in 2025.
  • A 4-year view of Change in Receivables shows it stood at -$14000.0 in 2022, then surged by 285.71% to $26000.0 in 2023, then tumbled by 92.31% to $2000.0 in 2024, then crashed by 450.0% to -$7000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$7000.0 in Q2 2025, -$8000.0 in Q1 2025, and $2000.0 in Q4 2024.